We propose to investigate the hypothesis that the chronic tissue damage associated with long-term diabetes mellitus may arise in part from in situ immune complex formation by accumulated immunoglobulins and/or antigens covalently bound to long-lived structural proteins which have undergone excessive nonenzymatic glycosylation with subsequent generation of reactive carbonyls. In the diabetic kidney, such immobilized immune complexes may serve as a chronic stimulus for tissue destruction by macrophages.
The specific aims of the studies described in this proposal are to: I) Characterize the covalent trapping of lysine and proteins by nonenzymatically glycosylated collagen (chemical and kinetic studies), using soluble collagen immobilized on Agarose. The effect of time and reactant concentrations will be evaluated, and binding will be assessed both in vitro and in vivo; II) Quantitate in situ formation of immune complexes by antigen or antibody bound covalently to nonenzymatically glycosylated collagen, using radioiodinated soluble proteins; II) Investigate the effect of immune complexes bound to glycosylated collagen on macrophage tissue-injury mechanisms. Phagocytosis will be evaluated using antibody-sensitized sheep erythrocytes labelled with 51Cr, and hydrolytic enzyme secretion will be investigated by measuring selected glycohydrolases, neutral proteases, and plasminogen activator; IV) Evaluate the effect of diabetes and high in vitro glucose concentration on macrophage response to nonenzymatically glycosylated collagen-bound immune complexes. Results from these studies may provide a basis for future development of new therapeutic agents useful in the treatment of diabetic complications.

Project Start
1984-04-01
Project End
1987-03-31
Budget Start
1985-04-01
Budget End
1986-03-31
Support Year
2
Fiscal Year
1985
Total Cost
Indirect Cost
Name
Rockefeller University
Department
Type
Graduate Schools
DUNS #
071037113
City
New York
State
NY
Country
United States
Zip Code
10065
Vlassara, H; Moldawer, L; Chan, B (1989) Macrophage/monocyte receptor for nonenzymatically glycosylated protein is upregulated by cachectin/tumor necrosis factor. J Clin Invest 84:1813-20
Vlassara, H; Brownlee, M; Manogue, K R et al. (1988) Cachectin/TNF and IL-1 induced by glucose-modified proteins: role in normal tissue remodeling. Science 240:1546-8
Vlassara, H; Brownlee, M; Cerami, A (1988) Specific macrophage receptor activity for advanced glycosylation end products inversely correlates with insulin levels in vivo. Diabetes 37:456-61
Brownlee, M; Cerami, A; Vlassara, H (1988) Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 318:1315-21
Brownlee, M; Cerami, A; Vlassara, H (1988) Advanced products of nonenzymatic glycosylation and the pathogenesis of diabetic vascular disease. Diabetes Metab Rev 4:437-51
Radoff, S; Vlassara, H; Cerami, A (1988) Characterization of a solubilized cell surface binding protein on macrophages specific for proteins modified nonenzymatically by advanced glycosylated end products. Arch Biochem Biophys 263:418-23
Vlassara, H; Valinsky, J; Brownlee, M et al. (1987) Advanced glycosylation endproducts on erythrocyte cell surface induce receptor-mediated phagocytosis by macrophages. A model for turnover of aging cells. J Exp Med 166:539-49
Brownlee, M; Vlassara, H; Kooney, A et al. (1986) Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking. Science 232:1629-32
Brownlee, M; Vlassara, H; Cerami, A (1986) Trapped immunoglobulins on peripheral nerve myelin from patients with diabetes mellitus. Diabetes 35:999-1003
Cerami, A; Vlassara, H; Brownlee, M (1986) Role of nonenzymatic glycosylation in atherogenesis. J Cell Biochem 30:111-20

Showing the most recent 10 out of 14 publications